co.don AG Logo

co.don AG

ISIN: DE000A3E5C08 | Ticker: CNW
Sector: Health CareSub-Industry: Health Care Equipment
Country: Germany

About co.don AG

Company Description

CO.DON AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells ("autologous chondrocytes"). CO.DON's method is currently used in over 200 clinics in Germany and more than 17,000 patients have already been treated. In July 2017 CO.DON AG received central EU marketing authorisation for this product. At the Leipzig site, CO.DON has built one of the largest and most modern facilities for the production of human cells on an industrial scale for in-house and contract manufacturing.

Year founded


Served area





Warthestraße 21, 14513 Teltow – Germany

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
21.10.21 Günther, Bernd Supervisory board Buy EUR 35.84
20.10.21 Laik, Robin Board Other EUR 10,348,300.00
20.10.21 ELBER GmbH Close relation Other EUR 10,179,000.00
20.10.21 Rofalski, Volker Supervisory board Other EUR 292,500.00
20.10.21 Müller, Dr. Axel Supervisory board Other EUR 195,000.00
20.10.21 Laumann, Johannes Board Other EUR 131,625.00
20.10.21 Laik, Louisa Close relation Other EUR 129,987.00
20.10.21 Laik, Daniel Close relation Other EUR 97,500.00
20.10.21 Friedrich, Neela Close relation Other EUR 64,993.50
20.10.21 Schleede, Dr. Kristian Board Other EUR 29,250.00

Capital markets information




Health Care

Industry Group

Health Care Equipment & Services


Health Care Equipment & Supplies


Health Care Equipment

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.